Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. UPLOAD Other SEC-generated Letter
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. S-1 Offering Registration Statement
  4. 3 Insider Initial Statement of Ownership
  5. 8-K Event Material agreement · Unregistered share sale · Executive or director change
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. SC 13G Stake Amended Statement of Ownership
  10. 10-Q Report Quarterly Report
  11. SC 13G Stake Amended Statement of Ownership
  12. SC 13D Stake Beneficial Ownership Report
  13. 8-K Event Executive or director change · Other events
  14. 424B3 Offering Prospectus
  15. EFFECT Other Notice of Effectiveness
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. UPLOAD Other SEC-generated Letter
  18. 3 Insider Initial Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. S-1 Offering Registration Statement

Page 19 of 77 · 1,525 filings